Global Mumps Virus Vaccine Live Market Growth 2026-2032

January 2026 | 83 pages | ID: G04EF577DE54EN
LP Information

Abstracts

The global Mumps Virus Vaccine Live market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

The mumps virus vaccine live is a live virus vaccine prepared using attenuated technology. It is used to prevent mumps, an acute respiratory infectious disease caused by the mumps virus. The virus contained in the vaccine has been weakened and will not cause disease, but can stimulate the body to produce immunity. After vaccination, it can effectively improve the resistance of children and adolescents to mumps and reduce the incidence rate. In my country, it is generally recommended that children aged 1-15 and adults who have not had mumps should be vaccinated with this vaccine.

United States market for Mumps Virus Vaccine Live is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Mumps Virus Vaccine Live is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Mumps Virus Vaccine Live is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Mumps Virus Vaccine Live players cover Merck, GSK, SINOVAC, AIM Vaccine, Shanghai Institute of Biological Products, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the ?Mumps Virus Vaccine Live Industry Forecast? looks at past sales and reviews total world Mumps Virus Vaccine Live sales in 2025, providing a comprehensive analysis by region and market sector of projected Mumps Virus Vaccine Live sales for 2026 through 2032. With Mumps Virus Vaccine Live sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mumps Virus Vaccine Live industry.

This Insight Report provides a comprehensive analysis of the global Mumps Virus Vaccine Live landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mumps Virus Vaccine Live portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Mumps Virus Vaccine Live market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mumps Virus Vaccine Live and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mumps Virus Vaccine Live.

This report presents a comprehensive overview, market shares, and growth opportunities of Mumps Virus Vaccine Live market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Single-dose Medication
• Combination Medication

Segmentation by Application:

• Children
• Adults

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Merck
• GSK
• SINOVAC
• AIM Vaccine
• Shanghai Institute of Biological Products

Key Questions Addressed in this Report
What is the 10-year outlook for the global Mumps Virus Vaccine Live market?
What factors are driving Mumps Virus Vaccine Live market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mumps Virus Vaccine Live market opportunities vary by end market size?
How does Mumps Virus Vaccine Live break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Mumps Virus Vaccine Live Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Mumps Virus Vaccine Live by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Mumps Virus Vaccine Live by Country/Region, 2021, 2025 & 2032
2.2 Mumps Virus Vaccine Live Segment by Type
  2.2.1 Single-dose Medication
  2.2.2 Combination Medication
  2.2.3 Mumps Virus Vaccine Live Sales by Type
    2.2.3.1 Global Mumps Virus Vaccine Live Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Mumps Virus Vaccine Live Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Mumps Virus Vaccine Live Sale Price by Type (2021-2026)
2.3 Mumps Virus Vaccine Live Segment by Application
  2.3.1 Children
  2.3.2 Adults
  2.3.3 Mumps Virus Vaccine Live Sales by Application
    2.3.3.1 Global Mumps Virus Vaccine Live Sale Market Share by Application (2021-2026)
    2.3.3.2 Global Mumps Virus Vaccine Live Revenue and Market Share by Application (2021-2026)
    2.3.3.3 Global Mumps Virus Vaccine Live Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Mumps Virus Vaccine Live Breakdown Data by Company
  3.1.1 Global Mumps Virus Vaccine Live Annual Sales by Company (2021-2026)
  3.1.2 Global Mumps Virus Vaccine Live Sales Market Share by Company (2021-2026)
3.2 Global Mumps Virus Vaccine Live Annual Revenue by Company (2021-2026)
  3.2.1 Global Mumps Virus Vaccine Live Revenue by Company (2021-2026)
  3.2.2 Global Mumps Virus Vaccine Live Revenue Market Share by Company (2021-2026)
3.3 Global Mumps Virus Vaccine Live Sale Price by Company
3.4 Key Manufacturers Mumps Virus Vaccine Live Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Mumps Virus Vaccine Live Product Location Distribution
  3.4.2 Players Mumps Virus Vaccine Live Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR MUMPS VIRUS VACCINE LIVE BY GEOGRAPHIC REGION

4.1 World Historic Mumps Virus Vaccine Live Market Size by Geographic Region (2021-2026)
  4.1.1 Global Mumps Virus Vaccine Live Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Mumps Virus Vaccine Live Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Mumps Virus Vaccine Live Market Size by Country/Region (2021-2026)
  4.2.1 Global Mumps Virus Vaccine Live Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Mumps Virus Vaccine Live Annual Revenue by Country/Region (2021-2026)
4.3 Americas Mumps Virus Vaccine Live Sales Growth
4.4 APAC Mumps Virus Vaccine Live Sales Growth
4.5 Europe Mumps Virus Vaccine Live Sales Growth
4.6 Middle East & Africa Mumps Virus Vaccine Live Sales Growth

5 AMERICAS

5.1 Americas Mumps Virus Vaccine Live Sales by Country
  5.1.1 Americas Mumps Virus Vaccine Live Sales by Country (2021-2026)
  5.1.2 Americas Mumps Virus Vaccine Live Revenue by Country (2021-2026)
5.2 Americas Mumps Virus Vaccine Live Sales by Type (2021-2026)
5.3 Americas Mumps Virus Vaccine Live Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Mumps Virus Vaccine Live Sales by Region
  6.1.1 APAC Mumps Virus Vaccine Live Sales by Region (2021-2026)
  6.1.2 APAC Mumps Virus Vaccine Live Revenue by Region (2021-2026)
6.2 APAC Mumps Virus Vaccine Live Sales by Type (2021-2026)
6.3 APAC Mumps Virus Vaccine Live Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Mumps Virus Vaccine Live by Country
  7.1.1 Europe Mumps Virus Vaccine Live Sales by Country (2021-2026)
  7.1.2 Europe Mumps Virus Vaccine Live Revenue by Country (2021-2026)
7.2 Europe Mumps Virus Vaccine Live Sales by Type (2021-2026)
7.3 Europe Mumps Virus Vaccine Live Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Mumps Virus Vaccine Live by Country
  8.1.1 Middle East & Africa Mumps Virus Vaccine Live Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Mumps Virus Vaccine Live Revenue by Country (2021-2026)
8.2 Middle East & Africa Mumps Virus Vaccine Live Sales by Type (2021-2026)
8.3 Middle East & Africa Mumps Virus Vaccine Live Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mumps Virus Vaccine Live
10.3 Manufacturing Process Analysis of Mumps Virus Vaccine Live
10.4 Industry Chain Structure of Mumps Virus Vaccine Live

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Mumps Virus Vaccine Live Distributors
11.3 Mumps Virus Vaccine Live Customer

12 WORLD FORECAST REVIEW FOR MUMPS VIRUS VACCINE LIVE BY GEOGRAPHIC REGION

12.1 Global Mumps Virus Vaccine Live Market Size Forecast by Region
  12.1.1 Global Mumps Virus Vaccine Live Forecast by Region (2027-2032)
  12.1.2 Global Mumps Virus Vaccine Live Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Mumps Virus Vaccine Live Forecast by Type (2027-2032)
12.7 Global Mumps Virus Vaccine Live Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Merck
  13.1.1 Merck Company Information
  13.1.2 Merck Mumps Virus Vaccine Live Product Portfolios and Specifications
  13.1.3 Merck Mumps Virus Vaccine Live Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Merck Main Business Overview
  13.1.5 Merck Latest Developments
13.2 GSK
  13.2.1 GSK Company Information
  13.2.2 GSK Mumps Virus Vaccine Live Product Portfolios and Specifications
  13.2.3 GSK Mumps Virus Vaccine Live Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 GSK Main Business Overview
  13.2.5 GSK Latest Developments
13.3 SINOVAC
  13.3.1 SINOVAC Company Information
  13.3.2 SINOVAC Mumps Virus Vaccine Live Product Portfolios and Specifications
  13.3.3 SINOVAC Mumps Virus Vaccine Live Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 SINOVAC Main Business Overview
  13.3.5 SINOVAC Latest Developments
13.4 AIM Vaccine
  13.4.1 AIM Vaccine Company Information
  13.4.2 AIM Vaccine Mumps Virus Vaccine Live Product Portfolios and Specifications
  13.4.3 AIM Vaccine Mumps Virus Vaccine Live Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 AIM Vaccine Main Business Overview
  13.4.5 AIM Vaccine Latest Developments
13.5 Shanghai Institute of Biological Products
  13.5.1 Shanghai Institute of Biological Products Company Information
  13.5.2 Shanghai Institute of Biological Products Mumps Virus Vaccine Live Product Portfolios and Specifications
  13.5.3 Shanghai Institute of Biological Products Mumps Virus Vaccine Live Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Shanghai Institute of Biological Products Main Business Overview
  13.5.5 Shanghai Institute of Biological Products Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Mumps Virus Vaccine Live Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Mumps Virus Vaccine Live Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Single-dose Medication
Table 4. Major Players of Combination Medication
Table 5. Global Mumps Virus Vaccine Live Sales by Type (2021-2026) & (KG)
Table 6. Global Mumps Virus Vaccine Live Sales Market Share by Type (2021-2026)
Table 7. Global Mumps Virus Vaccine Live Revenue by Type (2021-2026) & ($ million)
Table 8. Global Mumps Virus Vaccine Live Revenue Market Share by Type (2021-2026)
Table 9. Global Mumps Virus Vaccine Live Sale Price by Type (2021-2026) & (US$/G)
Table 10. Global Mumps Virus Vaccine Live Sale by Application (2021-2026) & (KG)
Table 11. Global Mumps Virus Vaccine Live Sale Market Share by Application (2021-2026)
Table 12. Global Mumps Virus Vaccine Live Revenue by Application (2021-2026) & ($ million)
Table 13. Global Mumps Virus Vaccine Live Revenue Market Share by Application (2021-2026)
Table 14. Global Mumps Virus Vaccine Live Sale Price by Application (2021-2026) & (US$/G)
Table 15. Global Mumps Virus Vaccine Live Sales by Company (2021-2026) & (KG)
Table 16. Global Mumps Virus Vaccine Live Sales Market Share by Company (2021-2026)
Table 17. Global Mumps Virus Vaccine Live Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Mumps Virus Vaccine Live Revenue Market Share by Company (2021-2026)
Table 19. Global Mumps Virus Vaccine Live Sale Price by Company (2021-2026) & (US$/G)
Table 20. Key Manufacturers Mumps Virus Vaccine Live Producing Area Distribution and Sales Area
Table 21. Players Mumps Virus Vaccine Live Products Offered
Table 22. Mumps Virus Vaccine Live Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Mumps Virus Vaccine Live Sales by Geographic Region (2021-2026) & (KG)
Table 26. Global Mumps Virus Vaccine Live Sales Market Share Geographic Region (2021-2026)
Table 27. Global Mumps Virus Vaccine Live Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Mumps Virus Vaccine Live Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Mumps Virus Vaccine Live Sales by Country/Region (2021-2026) & (KG)
Table 30. Global Mumps Virus Vaccine Live Sales Market Share by Country/Region (2021-2026)
Table 31. Global Mumps Virus Vaccine Live Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Mumps Virus Vaccine Live Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Mumps Virus Vaccine Live Sales by Country (2021-2026) & (KG)
Table 34. Americas Mumps Virus Vaccine Live Sales Market Share by Country (2021-2026)
Table 35. Americas Mumps Virus Vaccine Live Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Mumps Virus Vaccine Live Sales by Type (2021-2026) & (KG)
Table 37. Americas Mumps Virus Vaccine Live Sales by Application (2021-2026) & (KG)
Table 38. APAC Mumps Virus Vaccine Live Sales by Region (2021-2026) & (KG)
Table 39. APAC Mumps Virus Vaccine Live Sales Market Share by Region (2021-2026)
Table 40. APAC Mumps Virus Vaccine Live Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Mumps Virus Vaccine Live Sales by Type (2021-2026) & (KG)
Table 42. APAC Mumps Virus Vaccine Live Sales by Application (2021-2026) & (KG)
Table 43. Europe Mumps Virus Vaccine Live Sales by Country (2021-2026) & (KG)
Table 44. Europe Mumps Virus Vaccine Live Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Mumps Virus Vaccine Live Sales by Type (2021-2026) & (KG)
Table 46. Europe Mumps Virus Vaccine Live Sales by Application (2021-2026) & (KG)
Table 47. Middle East & Africa Mumps Virus Vaccine Live Sales by Country (2021-2026) & (KG)
Table 48. Middle East & Africa Mumps Virus Vaccine Live Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Mumps Virus Vaccine Live Sales by Type (2021-2026) & (KG)
Table 50. Middle East & Africa Mumps Virus Vaccine Live Sales by Application (2021-2026) & (KG)
Table 51. Key Market Drivers & Growth Opportunities of Mumps Virus Vaccine Live
Table 52. Key Market Challenges & Risks of Mumps Virus Vaccine Live
Table 53. Key Industry Trends of Mumps Virus Vaccine Live
Table 54. Mumps Virus Vaccine Live Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Mumps Virus Vaccine Live Distributors List
Table 57. Mumps Virus Vaccine Live Customer List
Table 58. Global Mumps Virus Vaccine Live Sales Forecast by Region (2027-2032) & (KG)
Table 59. Global Mumps Virus Vaccine Live Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Mumps Virus Vaccine Live Sales Forecast by Country (2027-2032) & (KG)
Table 61. Americas Mumps Virus Vaccine Live Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Mumps Virus Vaccine Live Sales Forecast by Region (2027-2032) & (KG)
Table 63. APAC Mumps Virus Vaccine Live Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Mumps Virus Vaccine Live Sales Forecast by Country (2027-2032) & (KG)
Table 65. Europe Mumps Virus Vaccine Live Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Mumps Virus Vaccine Live Sales Forecast by Country (2027-2032) & (KG)
Table 67. Middle East & Africa Mumps Virus Vaccine Live Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Mumps Virus Vaccine Live Sales Forecast by Type (2027-2032) & (KG)
Table 69. Global Mumps Virus Vaccine Live Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Mumps Virus Vaccine Live Sales Forecast by Application (2027-2032) & (KG)
Table 71. Global Mumps Virus Vaccine Live Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Merck Basic Information, Mumps Virus Vaccine Live Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Mumps Virus Vaccine Live Product Portfolios and Specifications
Table 74. Merck Mumps Virus Vaccine Live Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2021-2026)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. GSK Basic Information, Mumps Virus Vaccine Live Manufacturing Base, Sales Area and Its Competitors
Table 78. GSK Mumps Virus Vaccine Live Product Portfolios and Specifications
Table 79. GSK Mumps Virus Vaccine Live Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2021-2026)
Table 80. GSK Main Business
Table 81. GSK Latest Developments
Table 82. SINOVAC Basic Information, Mumps Virus Vaccine Live Manufacturing Base, Sales Area and Its Competitors
Table 83. SINOVAC Mumps Virus Vaccine Live Product Portfolios and Specifications
Table 84. SINOVAC Mumps Virus Vaccine Live Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2021-2026)
Table 85. SINOVAC Main Business
Table 86. SINOVAC Latest Developments
Table 87. AIM Vaccine Basic Information, Mumps Virus Vaccine Live Manufacturing Base, Sales Area and Its Competitors
Table 88. AIM Vaccine Mumps Virus Vaccine Live Product Portfolios and Specifications
Table 89. AIM Vaccine Mumps Virus Vaccine Live Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2021-2026)
Table 90. AIM Vaccine Main Business
Table 91. AIM Vaccine Latest Developments
Table 92. Shanghai Institute of Biological Products Basic Information, Mumps Virus Vaccine Live Manufacturing Base, Sales Area and Its Competitors
Table 93. Shanghai Institute of Biological Products Mumps Virus Vaccine Live Product Portfolios and Specifications
Table 94. Shanghai Institute of Biological Products Mumps Virus Vaccine Live Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2021-2026)
Table 95. Shanghai Institute of Biological Products Main Business
Table 96. Shanghai Institute of Biological Products Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Mumps Virus Vaccine Live
Figure 2. Mumps Virus Vaccine Live Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mumps Virus Vaccine Live Sales Growth Rate 2021-2032 (KG)
Figure 7. Global Mumps Virus Vaccine Live Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Mumps Virus Vaccine Live Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Mumps Virus Vaccine Live Sales Market Share by Country/Region (2025)
Figure 10. Mumps Virus Vaccine Live Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Single-dose Medication
Figure 12. Product Picture of Combination Medication
Figure 13. Global Mumps Virus Vaccine Live Sales Market Share by Type in 2026
Figure 14. Global Mumps Virus Vaccine Live Revenue Market Share by Type (2021-2026)
Figure 15. Mumps Virus Vaccine Live Consumed in Children
Figure 16. Global Mumps Virus Vaccine Live Market: Children (2021-2026) & (KG)
Figure 17. Mumps Virus Vaccine Live Consumed in Adults
Figure 18. Global Mumps Virus Vaccine Live Market: Adults (2021-2026) & (KG)
Figure 19. Global Mumps Virus Vaccine Live Sale Market Share by Application (2025)
Figure 20. Global Mumps Virus Vaccine Live Revenue Market Share by Application in 2026
Figure 21. Mumps Virus Vaccine Live Sales by Company in 2026 (KG)
Figure 22. Global Mumps Virus Vaccine Live Sales Market Share by Company in 2026
Figure 23. Mumps Virus Vaccine Live Revenue by Company in 2026 ($ millions)
Figure 24. Global Mumps Virus Vaccine Live Revenue Market Share by Company in 2026
Figure 25. Global Mumps Virus Vaccine Live Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Mumps Virus Vaccine Live Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Mumps Virus Vaccine Live Sales 2021-2026 (KG)
Figure 28. Americas Mumps Virus Vaccine Live Revenue 2021-2026 ($ millions)
Figure 29. APAC Mumps Virus Vaccine Live Sales 2021-2026 (KG)
Figure 30. APAC Mumps Virus Vaccine Live Revenue 2021-2026 ($ millions)
Figure 31. Europe Mumps Virus Vaccine Live Sales 2021-2026 (KG)
Figure 32. Europe Mumps Virus Vaccine Live Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Mumps Virus Vaccine Live Sales 2021-2026 (KG)
Figure 34. Middle East & Africa Mumps Virus Vaccine Live Revenue 2021-2026 ($ millions)
Figure 35. Americas Mumps Virus Vaccine Live Sales Market Share by Country in 2026
Figure 36. Americas Mumps Virus Vaccine Live Revenue Market Share by Country (2021-2026)
Figure 37. Americas Mumps Virus Vaccine Live Sales Market Share by Type (2021-2026)
Figure 38. Americas Mumps Virus Vaccine Live Sales Market Share by Application (2021-2026)
Figure 39. United States Mumps Virus Vaccine Live Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Mumps Virus Vaccine Live Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Mumps Virus Vaccine Live Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Mumps Virus Vaccine Live Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Mumps Virus Vaccine Live Sales Market Share by Region in 2026
Figure 44. APAC Mumps Virus Vaccine Live Revenue Market Share by Region (2021-2026)
Figure 45. APAC Mumps Virus Vaccine Live Sales Market Share by Type (2021-2026)
Figure 46. APAC Mumps Virus Vaccine Live Sales Market Share by Application (2021-2026)
Figure 47. China Mumps Virus Vaccine Live Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Mumps Virus Vaccine Live Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Mumps Virus Vaccine Live Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Mumps Virus Vaccine Live Revenue Growth 2021-2026 ($ millions)
Figure 51. India Mumps Virus Vaccine Live Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Mumps Virus Vaccine Live Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Mumps Virus Vaccine Live Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Mumps Virus Vaccine Live Sales Market Share by Country in 2026
Figure 55. Europe Mumps Virus Vaccine Live Revenue Market Share by Country (2021-2026)
Figure 56. Europe Mumps Virus Vaccine Live Sales Market Share by Type (2021-2026)
Figure 57. Europe Mumps Virus Vaccine Live Sales Market Share by Application (2021-2026)
Figure 58. Germany Mumps Virus Vaccine Live Revenue Growth 2021-2026 ($ millions)
Figure 59. France Mumps Virus Vaccine Live Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Mumps Virus Vaccine Live Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Mumps Virus Vaccine Live Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Mumps Virus Vaccine Live Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Mumps Virus Vaccine Live Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Mumps Virus Vaccine Live Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Mumps Virus Vaccine Live Sales Market Share by Application (2021-2026)
Figure 66. Egypt Mumps Virus Vaccine Live Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Mumps Virus Vaccine Live Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Mumps Virus Vaccine Live Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Mumps Virus Vaccine Live Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Mumps Virus Vaccine Live Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Mumps Virus Vaccine Live in 2026
Figure 72. Manufacturing Process Analysis of Mumps Virus Vaccine Live
Figure 73. Industry Chain Structure of Mumps Virus Vaccine Live
Figure 74. Channels of Distribution
Figure 75. Global Mumps Virus Vaccine Live Sales Market Forecast by Region (2027-2032)
Figure 76. Global Mumps Virus Vaccine Live Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Mumps Virus Vaccine Live Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Mumps Virus Vaccine Live Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Mumps Virus Vaccine Live Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Mumps Virus Vaccine Live Revenue Market Share Forecast by Application (2027-2032)